Literature DB >> 32471561

Does the Lung Cancer Field Need Another Third-Generation EGFR Tyrosine Kinase Inhibitor?

Fen Wang1, Alex A Adjei2.   

Abstract

Entities:  

Year:  2020        PMID: 32471561     DOI: 10.1016/j.jtho.2020.02.021

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  1 in total

Review 1.  Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Authors:  Xiaojing Du; Biwei Yang; Quanlin An; Yehuda G Assaraf; Xin Cao; Jinglin Xia
Journal:  Innovation (Camb)       Date:  2021-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.